Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromes.

Florensa L, Arenillas L, Calvo X, Pérez-Vila E, Montesdeoca S, Ferrer A, Woessner S.

Histol Histopathol. 2019 Aug;34(8):857-873. doi: 10.14670/HH-18-093. Epub 2019 Feb 19. Review.

PMID:
30779051
2.

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

Calvo X, Florensa L, Arenillas L.

Leukemia. 2018 May;32(5):1264-1266. doi: 10.1038/s41375-018-0064-6. Epub 2018 Feb 22. No abstract available.

PMID:
29483710
3.

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Calvo X, Florensa L, Arenillas L.

Leukemia. 2017 Jul 31. doi: 10.1038/leu.2017.237. [Epub ahead of print]

PMID:
28757616
4.

Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.

Ramos F, Robledo C, Pereira A, Pedro C, Benito R, de Paz R, Del Rey M, Insunza A, Tormo M, Díez-Campelo M, Xicoy B, Salido E, Sánchez-Del-Real J, Arenillas L, Florensa L, Luño E, Del Cañizo C, Sanz GF, María Hernández-Rivas J; Spanish Group for Myelodysplastic Syndromes (GESMD).

Am J Hematol. 2017 Sep;92(9):E534-E541. doi: 10.1002/ajh.24813. Epub 2017 Jul 19.

5.

Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Blanco ML, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu M, Ferrer A, Sanz GF, Florensa L.

Am J Hematol. 2017 Jul;92(7):614-621. doi: 10.1002/ajh.24732. Epub 2017 May 9.

6.

Reply to M.A. Lichtman.

Arenillas L, Calvo X, Sanz GF, Florensa L.

J Clin Oncol. 2017 Apr 20;35(12):1376-1377. doi: 10.1200/JCO.2016.71.3941. Epub 2017 Jan 30. No abstract available.

PMID:
28135144
7.

Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Ardanaz MT, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

Mod Pathol. 2016 Dec;29(12):1541-1551. doi: 10.1038/modpathol.2016.146. Epub 2016 Aug 26.

8.

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, Ardanaz MT, Pedro C, Tormo M, Marco V, Montoro J, Díez-Campelo M, Brunet S, Arrizabalaga B, Xicoy B, Andreu R, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

J Clin Oncol. 2016 Sep 20;34(27):3284-92. doi: 10.1200/JCO.2016.66.9705. Epub 2016 Jul 5.

PMID:
27382099
9.

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?

Saumell S, Solé F, Arenillas L, Montoro J, Valcárcel D, Pedro C, Sanzo C, Luño E, Giménez T, Arnan M, Pomares H, De Paz R, Arrizabalaga B, Jerez A, Martínez AB, Sánchez-Castro J, Rodríguez-Gambarte JD, Raya JM, Ríos E, Rodríguez-Rivera M, Espinet B, Florensa L.

PLoS One. 2015 Jun 12;10(6):e0129375. doi: 10.1371/journal.pone.0129375. eCollection 2015.

10.

Excessive lipid-phagocytosis of neutrophils in a patient with mesothelioma.

Morales-Indiano C, Carbonell Prat M, Castellà Fernández E, Arenillas Rocha L, Florensa L.

Diagn Cytopathol. 2015 Oct;43(10):830-2. doi: 10.1002/dc.23277. Epub 2015 May 5. No abstract available.

PMID:
25939815
11.

Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3.

Raya JM, Martín-Santos T, Luño E, Sanzo C, Perez-Sirvent ML, Such E, Navarro JT, Millá F, Alonso E, Domingo A, Rozman M, Díaz-Beva M, Batlle A, González-de-Villambrosia S, Tuset E, Vallespí T, Ortega M, Bermejo A, Martín-Ramos M, Peri V, Solé F, Florensa L; Grupo Español de Citología Hematológica (GECH), Working Group into the Sociedad Española de Hematología y Hemoterapia (SEHH).

Hematology. 2015 Sep;20(8):435-441. doi: 10.1179/1607845415Y.0000000003. Epub 2015 Feb 13.

PMID:
25680074
12.

PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.

Farrés J, Llacuna L, Martin-Caballero J, Martínez C, Lozano JJ, Ampurdanés C, López-Contreras AJ, Florensa L, Navarro J, Ottina E, Dantzer F, Schreiber V, Villunger A, Fernández-Capetillo O, Yélamos J.

Cell Death Differ. 2015 Jul;22(7):1144-57. doi: 10.1038/cdd.2014.202. Epub 2014 Dec 12.

13.

[Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].

Chen-Liang TH, Jerez A, Florensa L, Ortuño FJ.

Med Clin (Barc). 2015 Jun 22;144(12):571-2. doi: 10.1016/j.medcli.2014.07.021. Epub 2014 Sep 22. Spanish. No abstract available.

PMID:
25249393
14.

Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera.

Angona A, Alvarez-Larrán A, Bellosillo B, Martínez-Avilés L, Camacho L, Fernández-Rodríguez C, Pairet S, Longarón R, Ancochea Á, Senín A, Florensa L, Besses C.

Eur J Haematol. 2015 Mar;94(3):251-7. doi: 10.1111/ejh.12425. Epub 2014 Sep 13.

PMID:
25082530
15.

[Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].

Senín A, Arenillas L, Martínez-Avilés L, Fernández-Rodríguez C, Bellosillo B, Florensa L, Besses C, Álvarez-Larrán A.

Med Clin (Barc). 2015 Jun 8;144(11):487-90. doi: 10.1016/j.medcli.2014.03.020. Epub 2014 May 20. Spanish.

PMID:
24854193
16.

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.

Rozman M, Navarro JT, Arenillas L, Aventín A, Giménez T, Alonso E, Perea G, Camós M, Navarrete M, Tuset E, Florensa L, Millá F, Nomdedéu J, de la Banda E, Díaz-Beyá M, Pratcorona M, Garrido A, Navarro B, Brunet S, Sierra J, Esteve J; Grup Català de Citologia Hematològica and Spanish CETLAM Group (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas).

Ann Hematol. 2014 Oct;93(10):1695-703. doi: 10.1007/s00277-014-2100-6. Epub 2014 May 14.

PMID:
24824767
17.

Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia.

Saumell S, Florensa L, Rodríguez-Rivera M, Pedro C, Hernández-Rivas JM, Lumbreras E, Abáigar M, Collado R, Ivars D, Carbonell F, Marugán I, Tormo M, Botia M, Piñan MÁ, Ancín I, González T, Varela ND, Grau J, Granada I, Ruiz N, Martín ML, Fernández-Guijarro M, Duarte JJ, Calasanz MJ, Larrayoz MJ, Solé F.

Leuk Lymphoma. 2015 Jan;56(1):242-3. doi: 10.3109/10428194.2014.914197. Epub 2014 Jun 25. No abstract available.

PMID:
24724779
19.

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations.

Matarraz S, Paiva B, Díez-Campelo M, Bárrena S, Jara-Acevedo M, Gutiérrez ML, Sayagués JM, Sánchez ML, Bárcena P, Garrastazul MP, Berruezo MJ, Duran JM, Cerveró C, García-Erce JA, Florensa L, Méndez GD, Gutierrez O, Del Cañizo MC, van Dongen JJ, San Miguel JF, Orfao A.

Leukemia. 2014 Aug;28(8):1747-50. doi: 10.1038/leu.2014.103. Epub 2014 Mar 14. No abstract available.

PMID:
24625552
20.

Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Broséus J, Lippert E, Harutyunyan AS, Jeromin S, Zipperer E, Florensa L, Milosevic JD, Haferlach T, Germing U, Luño E, Schnittger S, Kralovics R, Girodon F.

Leukemia. 2014 Jun;28(6):1374-6. doi: 10.1038/leu.2014.49. Epub 2014 Jan 30. No abstract available.

PMID:
24476766
21.

Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Espinet B, Ferrer A, Bellosillo B, Nonell L, Salar A, Fernández-Rodríguez C, Puigdecanet E, Gimeno J, Garcia-Garcia M, Vela MC, Luño E, Collado R, Navarro JT, de la Banda E, Abrisqueta P, Arenillas L, Serrano C, Lloreta J, Miñana B, Cerutti A, Florensa L, Orfao A, Sanz F, Solé F, Dominguez-Sola D, Serrano S.

Clin Cancer Res. 2014 Feb 15;20(4):1007-19. doi: 10.1158/1078-0432.CCR-13-1077. Epub 2013 Dec 18.

22.

Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.

Arenillas L, Mallo M, Ramos F, Guinta K, Barragán E, Lumbreras E, Larráyoz MJ, De Paz R, Tormo M, Abáigar M, Pedro C, Cervera J, Such E, José Calasanz M, Díez-Campelo M, Sanz GF, Hernández JM, Luño E, Saumell S, Maciejewski J, Florensa L, Solé F.

Genes Chromosomes Cancer. 2013 Dec;52(12):1167-77. doi: 10.1002/gcc.22112. Epub 2013 Oct 7.

PMID:
24123380
23.

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.

Mallo M, Del Rey M, Ibáñez M, Calasanz MJ, Arenillas L, Larráyoz MJ, Pedro C, Jerez A, Maciejewski J, Costa D, Nomdedeu M, Diez-Campelo M, Lumbreras E, González-Martínez T, Marugán I, Such E, Cervera J, Cigudosa JC, Alvarez S, Florensa L, Hernández JM, Solé F.

Br J Haematol. 2013 Jul;162(1):74-86. doi: 10.1111/bjh.12354. Epub 2013 Apr 25.

PMID:
23614682
24.

Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?

Ademà V, Hernández JM, Abáigar M, Lumbreras E, Such E, Calull A, Dominguez E, Arenillas L, Mallo M, Cervera J, Marugán I, Tormo M, García F, González T, Luño E, Sanzo C, Martín ML, Fernández M, Costa D, Blázquez B, Barreña B, Marco F, Batlle A, Buño I, Martínez-Laperche C, Noriega V, Collado R, Ivars D, Carbonell F, Vallcorba I, Melero J, Delgado E, Vargas MT, Grau J, Salido M, Espinet B, Melero C, Florensa L, Pedro C, Solé F.

Leuk Res. 2013 Apr;37(4):416-21. doi: 10.1016/j.leukres.2012.12.010. Epub 2013 Jan 18.

PMID:
23337401
25.

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.

Senent L, Arenillas L, Luño E, Ruiz JC, Sanz G, Florensa L.

Haematologica. 2013 Apr;98(4):568-75. doi: 10.3324/haematol.2012.071449. Epub 2012 Oct 12.

26.

Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?

Puiggros A, Puigdecanet E, Salido M, Ferrer A, Abella E, Gimeno E, Nonell L, Herranz MJ, Galván AB, Rodríguez-Rivera M, Melero C, Pairet S, Bellosillo B, Serrano S, Florensa L, Solé F, Espinet B.

Leuk Lymphoma. 2013 May;54(5):986-95. doi: 10.3109/10428194.2012.731598. Epub 2012 Oct 16.

PMID:
22994157
27.

Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.

Saumell S, Florensa L, Luño E, Sanzo C, Cañizo C, Hernández JM, Cervera J, Gallart MA, Carbonell F, Collado R, Arenillas L, Pedro C, Bargay J, Nomdedeu B, Xicoy B, Vallespí T, Raya JM, Belloch L, Sanz GF, Solé F.

Br J Haematol. 2012 Nov;159(3):311-21. doi: 10.1111/bjh.12035. Epub 2012 Sep 7.

PMID:
22958186
28.

Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia.

Martínez-Avilés L, Álvarez-Larrán A, Besses C, Navarro G, Torres E, Longarón R, Angona A, Pedro C, Florensa L, Serrano S, Bellosillo B.

Ann Hematol. 2012 Oct;91(10):1555-62. doi: 10.1007/s00277-012-1502-6. Epub 2012 Jun 16.

PMID:
22706669
29.

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.

Broseus J, Florensa L, Zipperer E, Schnittger S, Malcovati L, Richebourg S, Lippert E, Cermak J, Evans J, Mounier M, Raya JM, Bailly F, Gattermann N, Haferlach T, Garand R, Allou K, Besses C, Germing U, Haferlach C, Travaglino E, Luno E, Pinan MA, Arenillas L, Rozman M, Perez Sirvent ML, Favre B, Guy J, Alonso E, Ahwij N, Jerez A, Hermouet S, Maynadié M, Cazzola M, Girodon F.

Haematologica. 2012 Jul;97(7):1036-41. doi: 10.3324/haematol.2011.053918. Epub 2012 Apr 24.

30.

Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas.

Salgado R, Gallardo F, Servitje O, Estrach T, García-Muret MP, Romagosa V, Florensa L, Serrano S, Salido M, Solé F, Pujol RM, Espinet B.

Cancer Genet. 2011 Jul;204(7):405-9. doi: 10.1016/j.cancergen.2011.05.004.

PMID:
21872828
31.

Deletion of TET2 gene in an acute myeloid leukemia case with a t(4;15)(q24;q26) characterized by glass needle based chromosome microdissection and oligonucleotide array.

Villa O, Mallo M, Kosyakova N, Salido M, Liehr T, Martínez-Avilés L, Pedro C, García-Aragonés M, Espinet B, Bellosillo B, Florensa L, Arenillas L, Cuscó I, Jurado LA, Solé F.

Leuk Res. 2011 Sep;35(9):e161-3. doi: 10.1016/j.leukres.2011.05.027. Epub 2011 Jun 17. No abstract available.

PMID:
21684005
32.

[Persistent polyclonal B-cell lymphocytosis: study of 35 cases].

Florensa L, Navarro JT, Pérez Vila ME, Domingo A, De la Banda E, Rozman M, Camós M, Millá F, Perea G, Alonso E, Ayats R, Aventín A, Cabezudo E, Espinet B, Merino A, Romero P, Sánchez C, Tuset E, Solé F, Feliu E, Fernández C, Gallart M, Vallespí T, Woessner S.

Med Clin (Barc). 2011 May 14;136(13):565-73. doi: 10.1016/j.medcli.2010.09.048. Epub 2011 Mar 10. Spanish.

PMID:
21396665
33.

Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia.

Albizua E, Gallardo M, Barrio S, Rapado I, Jimenez A, Ayala R, Rueda D, Sanchez-Espiridion B, Puigdecanet E, Espinet B, Florensa L, Besses C, Martinez-Lopez J.

Ann Hematol. 2011 Aug;90(8):939-46. doi: 10.1007/s00277-011-1179-2. Epub 2011 Feb 18.

PMID:
21331593
34.

Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients.

Besses C, Alvarez-Larrán A, Martínez-Avilés L, Mojal S, Longarón R, Salar A, Florensa L, Serrano S, Bellosillo B.

Br J Haematol. 2011 Feb;152(4):413-9. doi: 10.1111/j.1365-2141.2010.08467.x. Epub 2011 Jan 10.

PMID:
21219298
35.

Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.

Salido M, Martinez-Avilés L, Ademà V, Ferrer A, Espinet B, Garcia M, Salar A, Besses C, Florensa L, Serrano S, Bellosillo B, Solé F.

Leuk Res. 2011 Mar;35(3):e23-4. doi: 10.1016/j.leukres.2010.10.014. Epub 2010 Nov 18. No abstract available.

PMID:
21087793
36.

Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.

Baró C, Espinet B, Salido M, García M, Sánchez B, Florensa L, Bellosillo B, Serrano S, Solé F.

Leuk Res. 2011 Feb;35(2):256-9. doi: 10.1016/j.leukres.2010.09.011. Epub 2010 Oct 16.

PMID:
20952062
37.

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.

Mallo M, Cervera J, Schanz J, Such E, García-Manero G, Luño E, Steidl C, Espinet B, Vallespí T, Germing U, Blum S, Ohyashiki K, Grau J, Pfeilstöcker M, Hernández JM, Noesslinger T, Giagounidis A, Aul C, Calasanz MJ, Martín ML, Valent P, Collado R, Haferlach C, Fonatsch C, Lübbert M, Stauder R, Hildebrandt B, Krieger O, Pedro C, Arenillas L, Sanz MÁ, Valencia A, Florensa L, Sanz GF, Haase D, Solé F.

Leukemia. 2011 Jan;25(1):110-20. doi: 10.1038/leu.2010.231. Epub 2010 Sep 30.

PMID:
20882045
38.

TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study.

Mallo M, Osca G, Solórzano J, Arenillas L, Florensa L, Solé F.

Haematologica. 2010 Oct;95(10):1798-800. doi: 10.3324/haematol.2010.027920. Epub 2010 Jun 30. No abstract available.

39.

Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.

Nomdedeu J, Bussaglia E, Villamor N, Martinez C, Esteve J, Tormo M, Estivill C, Queipo MP, Guardia R, Carricondo M, Hoyos M, Llorente A, Juncà J, Gallart M, Domingo A, Bargay J, Mascaró M, Moraleda JM, Florensa L, Ribera JM, Gallardo D, Brunet S, Aventin A, Sierra J; Spanish CETLAM.

Leuk Res. 2011 Feb;35(2):163-8. doi: 10.1016/j.leukres.2010.05.015. Epub 2010 Jun 9.

PMID:
20542566
40.

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

Salido M, Baró C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E, Traverse-Glehen A, Berger F, Felman P, Thieblemont C, Gesk S, Athanasiadou A, Davis Z, Gardiner A, Milla F, Ferrer A, Mollejo M, Calasanz MJ, Florensa L, Espinet B, Luño E, Wlodarska I, Verhoef G, García-Granero M, Salar A, Papadaki T, Serrano S, Piris MA, Solé F.

Blood. 2010 Sep 2;116(9):1479-88. doi: 10.1182/blood-2010-02-267476. Epub 2010 May 17.

41.

Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?

Galván AB, Mallo M, Arenillas L, Salido M, Espinet B, Pedro C, Florensa L, Serrano S, Solé F.

Leuk Res. 2010 Sep;34(9):1242-5. doi: 10.1016/j.leukres.2010.03.022. Epub 2010 Apr 1.

PMID:
20362335
42.

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.

Espinet B, Salaverria I, Beà S, Ruiz-Xivillé N, Balagué O, Salido M, Costa D, Carreras J, Rodríguez-Vicente AE, Luís García J, Hernández-Rivas JM, Calasanz MJ, Siebert R, Ferrer A, Salar A, Carrió A, Polo N, García-Marco JA, Domingo A, González-Barca E, Romagosa V, Marugán I, López-Guillermo A, Millá F, Luís Mate J, Luño E, Sanzo C, Collado R, Oliver I, Monzó S, Palacín A, González T, Sant F, Salinas R, Ardanaz MT, Font L, Escoda L, Florensa L, Serrano S, Campo E, Solé F.

Genes Chromosomes Cancer. 2010 May;49(5):439-51. doi: 10.1002/gcc.20754.

PMID:
20143418
43.

FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.

Baró C, Espinet B, Salido M, Colomo L, Luño E, Florensa L, Ferrer A, Salar A, Campo E, Serrano S, Solé F.

Histol Histopathol. 2009 Nov;24(11):1399-404. doi: 10.14670/HH-24.1399.

PMID:
19760589
44.

Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients.

Alvarez-Larrán A, Bellosillo B, Martínez-Avilés L, Saumell S, Salar A, Abella E, Gimeno E, Serrano S, Florensa L, Sánchez B, Pedro C, Besses C.

Br J Haematol. 2009 Sep;146(5):504-9. doi: 10.1111/j.1365-2141.2009.07804.x. Epub 2009 Jul 8.

PMID:
19604233
45.

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.

Raya JM, Arenillas L, Domingo A, Bellosillo B, Gutiérrez G, Luño E, Piñán MA, Barbón M, Pérez-Sirvent ML, Muruzábal MJ, Yánez L, García L, Lemes A, Navarro JT, Elosegi A, Cortés MA, Villegas A, Durán MA, Ardanaz M, Florensa L; Grupo Español de Citología Hematológica (GECH), Working Group into the Asociación Española de Hematología y Hemoterapia (AEHH).

Int J Hematol. 2008 Nov;88(4):387-395. doi: 10.1007/s12185-008-0169-1. Epub 2008 Sep 27.

PMID:
18820995
46.

Blast cells with nuclear extrusions in the form of micronuclei are associated with MYC amplification in acute myeloid leukemia.

Villa O, Salido M, Pérez-Vila ME, Ferrer A, Arenillas L, Pedro C, Espinet B, Corzo C, Serrano S, Woessner S, Florensa L, Solé F.

Cancer Genet Cytogenet. 2008 Aug;185(1):32-6. doi: 10.1016/j.cancergencyto.2008.04.014.

PMID:
18656691
47.

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.

Mallo M, Arenillas L, Espinet B, Salido M, Hernández JM, Lumbreras E, del Rey M, Arranz E, Ramiro S, Font P, González O, Renedo M, Cervera J, Such E, Sanz GF, Luño E, Sanzo C, González M, Calasanz MJ, Mayans J, García-Ballesteros C, Amigo V, Collado R, Oliver I, Carbonell F, Bureo E, Insunza A, Yañez L, Muruzabal MJ, Gómez-Beltrán E, Andreu R, León P, Gómez V, Sanz A, Casasola N, Moreno E, Alegre A, Martín ML, Pedro C, Serrano S, Florensa L, Solé F.

Haematologica. 2008 Jul;93(7):1001-8. doi: 10.3324/haematol.13012.

48.

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.

Puigdecanet E, Espinet B, Lozano JJ, Sumoy L, Bellosillo B, Arenillas L, Alvarez-Larrán A, Solé F, Serrano S, Besses C, Florensa L.

Leukemia. 2008 Jul;22(7):1368-76. doi: 10.1038/leu.2008.112. Epub 2008 May 15.

PMID:
18480837
49.

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.

Ferran M, Gallardo F, Ferrer AM, Salar A, Pérez-Vila E, Juanpere N, Salgado R, Espinet B, Orfao A, Florensa L, Pujol RM.

Br J Dermatol. 2008 May;158(5):1129-33. doi: 10.1111/j.1365-2133.2008.08480.x. Epub 2008 Feb 22.

PMID:
18294313
50.

New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY).

Baró C, Salido M, Espinet B, Astier L, Domingo A, Granada I, Millà F, Carrió A, Costa D, Luño E, Hernández JM, Campo E, Florensa L, Ferrer A, Salar A, Bellosillo B, Besses C, Serrano S, Solé F.

Leuk Res. 2008 May;32(5):727-36. Epub 2007 Nov 19.

PMID:
18023866

Supplemental Content

Loading ...
Support Center